- Food fortified with folic acid helped lower overall rates of congenital heart defects in Canada.
- The effect was evident in some types of congenital heart defects but not all.
Embargoed until 3 p.m. CT / 4 p.m. ET Monday, August 29, 2016
DALLAS, Aug. 29, 2016 — Food fortified with folic acid, a B vitamin required in human diets for numerous biological functions, was associated with reduced rates of congenital heart defects, according to new research in the American Heart Association’s journal Circulation.
“Our study examined the effect of folic acid food fortification on each specific subtype of congenital heart disease based on the Canadian experience before and after food fortification was made mandatory in 1998,” said K.S. Joseph, M.D., Ph.D., the study’s senior author and professor in the Department of Obstetrics and Gynecology and the School of Population and Public Health at the University of British Columbia in Vancouver, Canada.
Controlling for influences such as maternal age, multiple births (twins, triplets), pregnancy complications, prenatal diagnosis and pregnancy terminations, researchers analyzed data from nearly 6 million Canadian births from 1990 to 2011 and found that folic acid food fortification was associated with an 11 percent reduction in rates of congenital heart defects overall.
They also found that the beneficial effects of folic acid were evident in some subtypes of congenital heart defects but not others, such as a:
- 27 percent reduction in conotruncal defects, or severe heart outflow tract abnormalities;
- 23 percent reduction in coarctation of the aorta — a narrowing of the major artery (the aorta) that carries blood to the body;
- 15 percent reduction in atrial and ventricular septal defects — holes in the wall separating heart chambers;
- however, no changes were seen with regard to chromosomally associated defects — abnormality in the number of an infant's chromosomes.
Canada mandated adding folic acid to all types of flour, enriched pasta and cornmeal, primarily aimed at preventing neural tube defects in 1998. The study’s findings are applicable to the U.S. population because food fortification with folic acid was implemented at approximately the same time and levels in the U.S. as Canada because of the North American Fair Trade Agreement of 1994, Joseph said.
Folic acid is especially important for rapid cell division and growth, for instance, when blood is being formed and in pregnancy when the fetus is growing rapidly. Folate deficiency can result in several different complications – the most important of these are neural tube defects (such as spina bifida, an abnormality of the spine and spinal cord) in babies and anemia (in which the number and function of red blood cells is affected leading to an inability of the blood to carry sufficient oxygen).
Joseph added that women who are likely to get pregnant should start taking folic acid supplements before getting pregnant as they may not necessarily receive adequate folate from diet alone.
It is estimated that there are about 650,000 to 1.3 million children and adults living with congenital heart disease in the United States. Ventricular septal defects are the most common type of defect in children and account for nearly 620,000 of the cases.
Co-authors are Shiliang Liu, M.D., Ph.D.; Wei Luo, M.B., M.Sc.; Juan Andrés León, M.D., M.Sc.; Sarka Lisonkova, M.D., Ph.D.; Michiel Van den Hof, M.D.; Jane Evans, Ph.D.; Ken Lim, M.D.; Julian Little, Ph.D.; Reg Sauve, M.D., M.P.H.; and Michael S. Kramer, M.D. Author disclosures are on the manuscript.
The study was funded by the Public Health Agency of Canada.
- A heart graphic is located in the right column of this release link http://newsroom.heart.org/news/folic-acid-fortified-food-linked-to-decline-in-congenital-heart-defects?preview=bfefc16edcbeb31689d92ce9d16de562
- After August 29, view the manuscript online.
- Increasing number of U.S. adults living with congenital heart defects
- Follow AHA/ASA news on Twitter @HeartNews.
- For updates and new science from the Circulation journal follow @CircAHA.
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association’s policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding.
For Media Inquiries and AHA/ASA Spokesperson Perspective: (214) 706-1173
Akeem Ranmal: (214) 706-1755; firstname.lastname@example.org
Julie Del Barto (national broadcast): (214) 706-1330; email@example.com
For Public Inquiries: (800)-AHA-USA1 (242-8721)
Life is why, science is how . . . we help people live longer, healthier lives.